YAOJI TECHNOLOGY(SZ:002605)2022-12-06 09:44Group 1: Company Overview and Acquisition Strategy - The company is focusing on its core business of playing cards, which provides stable cash flow, forming the basis for further expansion or transformation [1] - The acquisition of Wanshengda, a major domestic playing card manufacturer, is aimed at enhancing production capacity and distribution channels, thereby solidifying the company's leading position in the industry [2] - Post-acquisition, the company expects to leverage Wanshengda's brand and distribution network, which has minimal overlap with its own, to achieve significant market expansion [2] Group 2: Market Position and Competitive Landscape - The playing card industry is evolving from perfect competition to oligopoly, with high-end manufacturers gaining market share through automation and quality advantages [2] - The "Yaoji" brand has established a strong reputation for quality and design, becoming a core competitive asset for the company [2] - The company plans to continue leveraging the "Yaoji" brand influence to explore quality projects and innovative cooperation models in the "big entertainment" and "big health" sectors for sustainable long-term development [2] Group 3: Investment in Health Sector - The company is advancing its layout in the "big health" sector, focusing on immune cell therapy, with significant progress in its investment in Shanghai Cell Therapy Engineering Technology Research Center [3] - The new CAR-T and "Bai Ze Jian" cell therapy technologies have shown promising results in treating various solid tumors, enhancing the company's capabilities in the biomedicine industry [3] - Despite potential risks in legal, market, policy, and technological aspects, the company remains optimistic about the future of immune cell therapy [3]